BioCentury
ARTICLE | Company News

DNA Therapeutics, Onxeo deal

March 7, 2016 8:00 AM UTC

Onxeo will acquire DNA Therapeutics for EUR1.7 million ($1.9 million) in stock up front. DNA Therapeutics, which develops signal-interfering DNA (siDNA) molecules for cancer indications, is also eligi...